Strota / DRREDDY / Quarterly results

Dr. Reddy's Laboratories Q1 FY27 Results: Revenue, Profit and Share Price Reaction

Dr. Reddy's Laboratories' quarterly results from its filings with NSE, consolidated, with how the share price moved on each announcement.

Q1 FY27 (quarter to 30 Jun 2026): revenue ₹8,100 crore (-5.5% year on year), net profit ₹444 crore (-68.7% year on year), EPS ₹5.33. Announced 22 Jul 2026, 6:25 pm IST. The shares fell 1.39% on 23 Jul 2026, 0.87 points worse than the Nifty 50.
Revenue
₹8,100 cr
YoY -5.5% · QoQ +7.3%
Net profit
₹444 cr
YoY -68.7% · QoQ +101.1%
EPS (basic)
₹5.33
YoY -68.7%
Share price reaction
-1.4%
23 Jul 2026 · vs Nifty -0.9%

Revenue and net profit by quarter

RevenueNet profit
Q4 FY25 Revenue: ₹8,528 cr Q4 FY25 net profit: ₹1,593 cr Q4 FY25 Q1 FY26 Revenue: ₹8,572 cr Q1 FY26 net profit: ₹1,418 cr Q1 FY26 Q2 FY26 Revenue: ₹8,828 cr Q2 FY26 net profit: ₹1,347 cr Q2 FY26 Q3 FY26 Revenue: ₹8,753 cr Q3 FY26 net profit: ₹1,210 cr Q3 FY26 Q4 FY26 Revenue: ₹7,546 cr Q4 FY26 net profit: ₹221 cr Q4 FY26 Q1 FY27 Revenue: ₹8,100 cr Q1 FY27 net profit: ₹444 cr Q1 FY27

Every quarter

QuarterAnnouncedRevenueYoYNet profitYoYMarginEPSPrice reaction
Q1 FY2722 Jul 2026, 6:25 pm IST 8,100-5.5%444-68.7% 5.5%5.33 -1.4%
Q4 FY2612 May 2026, 5:37 pm IST 7,546-11.5%221-86.1% 2.9%2.65 -0.4%
Q3 FY2621 Jan 2026, 7:31 pm IST 8,753—1,210— 13.8%14.53 +5.2%
Q2 FY2624 Oct 2025, 11:28 pm IST 8,828—1,347— 15.3%16.18 +0.1%
Q1 FY2623 Jul 2025, 6:56 pm IST 8,572—1,418— 16.5%17.04 +1.4%
Q4 FY259 May 2025, 9:31 pm IST 8,528—1,593— 18.7%19.12 +3.4%

₹ crore. Consolidated figures; net profit is the share attributable to the company's owners where reported. Margin = net profit ÷ revenue. Year-on-year compares with the same quarter a year earlier.

How DRREDDY shares react to results

Across the last 6 results here, the shares rose on 4 and fell on 2. The average move was +1.40%, and the average size of the move either way 1.98%; the biggest was +5.21% after the Q3 FY26 results.

The reaction is the close of the first session that could trade on the news (the announcement day if it came before 3:30 pm, otherwise the next session) against the previous close. A few results don't explain a stock's move; markets also price guidance, commentary and what was expected.

Questions

What were Dr. Reddy's Laboratories' Q1 FY27 results?

For the quarter to 30 Jun 2026, Dr. Reddy's Laboratories reported revenue of ₹8,100 crore (-5.5% year on year) and net profit of ₹444 crore (-68.7%), with basic EPS of ₹5.33.

How did Dr. Reddy's Laboratories shares react to the Q1 results?

They fell 1.39% on 23 Jul 2026, the first session that could trade on the results (announced after the close); that was 0.87 points worse than the Nifty 50 that day.

When is Dr. Reddy's Laboratories' next results date?

No results date has been announced to NSE yet. Companies give advance notice of the board meeting; the results calendar lists every announced date.

Do Dr. Reddy's Laboratories shares usually rise after results?

In the last 6 results here they rose 4 times and fell 2 times, moving 1.98% on average either way.

About this data

From Dr. Reddy's Laboratories' Integrated Filing (Financials) XBRL with NSE, which listed companies use for quarterly results since 2025; announcement times are NSE's broadcast times (IST). Share prices are NSE closing prices. See DRREDDY stock page for price, open interest and deals, all results declared this week and the results calendar, and DRREDDY dividend history.